Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Blood. 2012 Jun 21; 119(25):5989-95.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antibodies, Monoclonal, Murine-Derived
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Immunologic Factors
Immunotherapy
Male
Middle Aged
Models, Biological
Purpura, Thrombocytopenic, Idiopathic
Time Factors
Treatment Outcome
Young Adult